• Home
  •  / Ribon Therapeutics

Ribon Therapeutics

    OverviewSuggest Edit

    Ribon Therapeutics is pioneering the discovery and development of monoPARP (mono ADP-ribose polymerase) inhibitors to block cancer cells’ fundamental ability to survive under stress


    TypePrivate
    Founded2015
    HQCambridge, USMap
    Websiteribontx.com
    View Jobs

    Recent NewsAll News

    Latest Updates

    Employees (est.) (Aug 2020)47(-2%)
    Cybersecurity ratingDMore

    Key People/Management at Ribon Therapeutics

    Victoria Richon

    Victoria Richon

    President and Chief Executive Officer, Director
    Jim Audia

    Jim Audia

    Director
    Heike Keilhack

    Heike Keilhack

    Senior Vice President of Biological Sciences
    Marian Nakada

    Marian Nakada

    Director
    Anja König

    Anja König

    Director
    Kevin Kuntz

    Kevin Kuntz

    Senior Vice President of Molecular Discovery
    Show more

    Ribon Therapeutics Office Locations

    Ribon Therapeutics has an office in Cambridge
    Cambridge, US (HQ)
    35 Cambridgepark Dr
    Show all (1)

    Ribon Therapeutics Financials and Metrics

    Summary Metrics

    Founding Date

    		2015

    Ribon Therapeutics investors

    		U.S. Venture Partners (USVP)

    Ribon Therapeutics Cybersecurity Score

    Cybersecurity ratingPremium dataset

    D

    66/100

    Learn more about about our premium products
    SecurityScorecard logo

    Ribon Therapeutics Online and Social Media Presence

    Ribon Therapeutics's Trends

    Embed Graph

    Ribon Therapeutics Blogs

    January 24, 2020

    Ribon Therapeutics to Present at Upcoming Scientific Conferences

    Cambridge, MA – Jan. 24, 2020 – Ribon Therapeutics, a clinical stage biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress … The post Ribon Therapeutics to Present at Upcoming Scientific Conferences appeared first on Ribon Therap…
    January 07, 2020

    Ribon Therapeutics Named as a Top Life Sciences Company to Watch in 2020

    BioSpace is proud to present its NextGen Bio “Class of 2020,” a list of up-and-coming life sciences companies in North America that launched* no earlier than mid-2018. The post Ribon Therapeutics Named as a Top Life Sciences Company to Watch in 2020 appeared first on Ribon Therapeutics.
    December 18, 2019

    Ribon Therapeutics Strengthens Scientific Advisory Board with Appointment of Neal Rosen, M.D., Ph.D.

    Cambridge, MA – Dec. 18, 2019 – Ribon Therapeutics, a clinical stage biotechnology company developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress … The post Ribon Therapeutics Strengthens Scientific Advisory Board with Appointment of Neal Rosen, M.D., …
    September 04, 2019

    Ribon Therapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of RBN-2397, a First-In-Class PARP7 Inhibitor

    PARP7 is a Novel Tumor Dependency, Enabling Cancer Cells to Evade the Immune System First Ever Clinical Evaluation of a monoPARP Inhibitor Cambridge, MA – … The post Ribon Therapeutics Announces Dosing of First Patient in Phase 1 Clinical Trial of RBN-2397, a First-In-Class PARP7 Inhibitor appeared …
    August 06, 2019

    Ribon Therapeutics Strengthens Management Team with Appointment of Sudha Parasuraman, M.D., as Chief Medical Officer and Edward Stewart as Chief Business Officer

    Cambridge, MA – Aug. 6, 2019 – Ribon Therapeutics, a clinical stage biotechnology company, developing first-in-class therapeutics targeting novel enzyme families activated under cellular stress … The post Ribon Therapeutics Strengthens Management Team with Appointment of Sudha Parasuraman, M.D., as …
    December 14, 2018

    Ribon Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer

    Proin eget tortor risus. Quisque velit nisi, pretium ut lacinia in, elementum id enim. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec rutrum congue leo eget malesuada. Curabitur non nulla sit amet nisl tempus convallis quis ac lectus. The post Ribon Raises $65 Million to Advance Pipe…
    Show more

     Ribon Therapeutics Frequently Asked Questions

    • When was Ribon Therapeutics founded?

      Ribon Therapeutics was founded in 2015.

    • Who are Ribon Therapeutics key executives?

      Ribon Therapeutics's key executives are Victoria Richon, Jim Audia and Heike Keilhack.

    • How many employees does Ribon Therapeutics have?

      Ribon Therapeutics has 47 employees.

    • Who are Ribon Therapeutics competitors?

      Competitors of Ribon Therapeutics include OncoDNA, Outlook Therapeutics and Virttu Biologics.

    • Where is Ribon Therapeutics headquarters?

      Ribon Therapeutics headquarters is located at 35 Cambridgepark Dr, Cambridge.

    • Where are Ribon Therapeutics offices?

      Ribon Therapeutics has an office in Cambridge.

    • How many offices does Ribon Therapeutics have?

      Ribon Therapeutics has 1 office.